Characteristics | Trans male | Trans female | Non-binary | Exploratory phase | Total | |||||
---|---|---|---|---|---|---|---|---|---|---|
n (%) | 95%ā+āCI | n (%) | 95%ā+āCI | n (%) | 95%ā+āCI | n (%) | 95%ā+āCI | n (%) | 95%ā+āCI | |
Sex assigned at birth* | ||||||||||
Ā Female | 15 (60) | 40.69ā76.63 | ā | ā | 2 (8) | 10.86ā26.10 | 8 (32) | 17.06ā51.73 | 25 (58.14) | 42.12ā72.98 |
Ā Male | ā | ā | 12 (66.67) | 43.57ā83.89 | ā | ā | 6 (33.33) | 16.10ā56.42 | 18 (41.86) | 27.01ā57.87 |
Age groups | ||||||||||
Ā 0ā4Ā years | ā | ā | ā | ā | ā | ā | 3 (100) | Ā | 3 (6.98) | 14.62ā19.06 |
Ā 5ā9Ā years | ā | ā | 2 (66.67) | 20.24ā94.37 | ā | ā | 1 (33.33) | 5.62ā79.75 | 3 (6.98) | 14.62ā19.06 |
Ā 10ā14Ā years | 4 (36.36) | 14.98ā64.80 | 1 (9.09) | 0.00ā39.90 | 2 (18.18) | 3.98ā48.84 | 4 (36.36) | 14.98ā64.80 | 11 (25.58) | 13.51ā41.17 |
Ā 15ā17Ā years | 11 (42.31) | 25.52ā61.07 | 9 (34.62) | 19.31ā53.87 | ā | ā | 6 (23.07) | 10.70ā42.38 | 26 (60.46) | 44.40ā75.02 |
Depression | ||||||||||
Ā No | 4 (16.67) | 4.73ā37.38 | 10 (41.67) | 22.10ā63.35 | 1 (4.17) | 0.1ā21.12 | 9 (37.50) | 18.79ā59.40 | 24 (55.81) | 39.87ā70.92 |
Ā Yes | 11 (57.89) | 33.49ā79.74 | 2 (10.52) | 13.01ā33.13 | 1 (5.26) | 1.3ā26.02 | 5 (26.32) | 9.14ā51.20 | 19 (44.18) | 29.07ā60.12 |
Anxiety | ||||||||||
Ā No | 6 (22.22) | 8.62ā42.25 | 11 (40.74) | 22.38ā61.20 | 1 (3.70) | 0.0ā18.79 | 9 (33.33) | 16.51ā53.96 | 27 (62.79) | 46.72ā77.02 |
Ā Yes | 9 (56.25) | 29.87ā80.24 | 1 (6.25) | 1.58ā30.23 | 1 (6.25) | 1.58ā30.23 | 5 (31.25) | 11.01ā58.66 | 16 (37.21) | 22.97ā53.27 |
Use of psychotropic drugs | ||||||||||
Ā No | 5 (22.72) | 7.82ā45.37 | 8 (36.36) | 17.19ā59.34 | ā | ā | 9 (40.90) | 20.70ā63.64 | 22 (51.16) | 35.46ā66.69 |
Ā Yes | 10 (47.62) | 25.71ā70.21 | 4 (19.05) | 5.44ā41.90 | 2 (9.52) | 1.17ā30.37 | 5 (23.81) | 8.21ā47.16 | 21 (48.83) | 33.30ā64.53 |